h2o Therapeutics will soon be able to call on the marketing reach of pharma distributor AmerisourceBergen for its app for patients with Parkinson’s disease.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS